-       Report 
   - May 2025
    -  100 Pages 
    Global
   
   From       €4397EUR$4,900USD£3,859GBP 
                -       Report 
   - September 2025
    -  250 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                  -       Report 
   - January 2025
    -  308 Pages 
    Global
   
   From       €5707EUR$6,360USD£5,009GBP 
      €7134EUR$7,950USD£6,261GBP 
                  -       Drug Pipelines 
   - April 2025
    -  60 Pages 
    Global
   
   From       €1077EUR$1,200USD£945GBP 
      €1346EUR$1,500USD£1,181GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €897EUR$1,000USD£788GBP 
      €1122EUR$1,250USD£984GBP 
                 -       Report 
   - March 2025
    -  81 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                -       Report 
   - September 2025
    -  250 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - April 2025
    -  175 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - April 2023
    -  114 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - May 2022
    -  81 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                      Interleukin 2 (IL-2) is a cytokine used in immunosuppressive drug therapy. It is used to treat autoimmune diseases, such as rheumatoid arthritis, psoriasis, and Crohn's disease. IL-2 works by suppressing the immune system, which helps to reduce inflammation and pain. It is also used to treat certain types of cancer, such as renal cell carcinoma and melanoma.
IL-2 is available in both injectable and oral forms. The injectable form is administered intravenously, while the oral form is taken as a    pill. The dosage and frequency of administration depend on the patient's condition and the severity of the disease.
The IL-2 market is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Other companies include Amgen, Genentech, and Eli Lilly. Show Less   Read more